Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn researchers discover bone stem cells

A population of stem cells with the ability to generate new bone has been discovered by a group of researchers at the UConn School of Dental...

| By Kelley Gipson

Yale researchers study liver metabolism

Many health problems in the developed world stem from the disruption of a delicate metabolic balance between glucose production and energy utilization in the liver....

| By Kelley Gipson

Farmington JAX is studying the genome in 3D

Three-dimensional genomic compartments and sub-compartments help regulate gene expression across the genome. As more data comes out about 3D genomic structures, there is an increasing...

| By Kelley Gipson

Sema4 and VieCure collaborate re oncology care

Sema4, a patient-centered health intelligence company, and VieCure, an artificial intelligence informatics company, have announced a strategic collaboration. Through this alliance, Sema4 data scientists will be...

| By Kelley Gipson

Biopharma companies respond to Corona virus

So many companies are doing battle to fight the COVID19 virus. Connecticut companies such as Nanoviricides, working on treatment, and Protein Sciences, working on a vaccine,...

| By Kelley Gipson

Biohaven migraine drug gets FDA green light

The has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults. NURTEC ODT is the first FDA-approved product for Biohaven. “NURTEC ODT...

| By Kelley Gipson

3D printers adapted for musculoskeletal injuries

Biomedical engineers at the UConn School of Dental Medicine recently developed a handheld 3D bioprinter that could revolutionize the way musculoskeletal surgical procedures are performed....

| By Kelley Gipson

Rebiotix completes Phase 3 trial enrollment

Investigators have completed enrollment in a phase 3 trial set to investigate RBX2660 from Rebiotix, a therapy that uses the gut microbiota to treat Clostridioides...

| By Kelley Gipson

NanoViricides begins work on coronavirus

Shelton’s NanoViricides is advancing its skin cream for the shingles virus and working on a treatment for the deadly coronavirus. The company, which develops so-called...